The melanocortin system: MC4R, hunger, and its drugs

Key takeaways

• The melanocortin system is one peptide family. A precursor called POMC is cut into ACTH and the alpha, beta, and gamma melanocyte-stimulating hormones, which act on five receptors named MC1R through MC5R .
• Each receptor has a different job: MC1R sets skin and hair pigment, MC2R is the ACTH receptor that drives adrenal cortisol, MC3R and MC4R in the brain control appetite and energy, and MC5R works in exocrine glands .
• MC4R is the metabolic one. Mutations in it are the most common single-gene cause of early-onset obesity, roughly 2 to 5 percent of cases .
• Three FDA-approved drugs each target a melanocortin receptor: afamelanotide (Scenesse, 2019) on MC1R, setmelanotide (Imcivree, 2020) on MC4R, and bremelanotide (Vyleesi, 2019) on MC4R .
• Selective is not exclusive. Because the receptors share ligands, setmelanotide nudges MC1R too, which is why skin and moles can darken on it, reversibly; the gray-market tanning peptide melanotan II hits the same family and is unapproved .

Five receptors, one hormone family, three approved drugs

Read the table as a map, not a menu. The reason a single small family covers pigment, stress hormones, hunger, and gland output is that evolution reused one signaling lock in different rooms of the body. That is also why a drug built for one room can leak into another, which is the thread running through the rest of this piece.

The wiring: one precursor cut into several signals

Everything starts with one protein. POMC (pro-opiomelanocortin) is cut by enzymes into smaller active pieces: ACTH and the alpha, beta, and gamma melanocyte-stimulating hormones . Those pieces are the keys. The five MC receptors are the locks, and the keys are not interchangeable. MC2R, the adrenal cortisol receptor, only answers to ACTH; the MSH peptides cannot open it. The other four read alpha-MSH well .

The system also has a brake. Two natural antagonists, agouti and agouti-related peptide (AgRP), compete with alpha-MSH at the receptors and push the opposite way. At MC4R, AgRP blocks the fullness signal and turns hunger back up . So appetite here is a tug-of-war between an on signal (alpha-MSH) and an off-the-brake signal (AgRP), not a single dial. Every drug below is just a synthetic key cut to fit one of these locks.

MC4R: the receptor the metabolic drugs are chasing

MC4R sits in the hypothalamus and is the system's appetite and energy switch: alpha-MSH presses it to lower hunger and raise energy use, and AgRP opposes it . When the gene itself is broken, the consequence is blunt. MC4R mutations are the most common single-gene cause of early-onset obesity, roughly 2 to 5 percent of cases . That makes the receptor the cleanest target in obesity pharmacology, and two approved drugs press it for completely different reasons.

Setmelanotide works because it supplies the missing key. In rare genetic obesity the leptin-to-MC4R pathway is cut upstream, so setmelanotide reaches past the break and switches MC4R on directly. In the pivotal trials, 8 of 10 (80 percent) POMC or PCSK1 deficiency patients and 5 of 11 (about 45 percent) LEPR deficiency patients lost at least 10 percent of body weight at roughly a year . For the full mechanism see our piece on how setmelanotide works and the genetic-obesity label guide.

Bremelanotide presses the same receptor in the brain to act on sexual desire rather than weight, which is why an appetite-family receptor ended up behind a libido drug. The shared receptor is also why the two share side-effect themes like nausea and pigment changes. The deeper evidence read is in our PT-141 / bremelanotide evidence map .

MC1R: why a hunger or desire drug can change your skin

MC1R is the pigment receptor. When alpha-MSH presses it on skin melanocytes, they make more eumelanin, the brown-black pigment behind tanning and hair color . This is the off-target that trips people up. Setmelanotide is selective for MC4R, but selective is not exclusive: it also nudges MC1R, so darker skin and deeper moles are common on it and reverse after stopping. The label treats that as expected mechanism, not contamination, which is why skin checks are part of monitoring .

One approved drug uses MC1R on purpose. Afamelanotide (Scenesse) is an MC1R agonist that makes skin build protective eumelanin without sunlight, approved in 2019 to reduce light-triggered pain in adults with erythropoietic protoporphyria, a rare disorder where light exposure causes severe skin pain . Same receptor as the tanning side effect above, used deliberately for a light-protection benefit instead.

The honest read

The melanocortin system is a tidy lesson in how biology reuses parts. One precursor, a handful of signals, five receptors, and the same family shows up in your skin, your adrenal glands, and your appetite. The approved drugs are precise keys cut for single locks, but none of them is perfectly exclusive, so the visible price of pressing one receptor is usually a smaller effect somewhere else in the family. Useful map, and a good reminder that a peptide aimed at one thing rarely does only that thing.

For research and educational purposes only. Not medical advice. Setmelanotide, bremelanotide, and afamelanotide are clinician-managed prescription drugs with specific approved indications, and melanotan II is an unapproved product with unverified contents.

pepSmart has not commissioned independent clinical review of this article.

More on how we work: Editorial process and contributor disclosure and our Sourcing posture.

Spot an error? Email corrections via /about.

Sources: 10 entries, all primary canon, last reviewed 2026-06-05.

Related tools

• Injection-site rotation overview - Public overview of the Pro site-rotation planner.
• Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
• BAC water calculator - Solve BAC water volume for a target concentration.
• Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
• Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
• Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.